Sissy Therese Sonnleitner1, Josef Fritz, Malgorzata Bednarska, Raphaela Baumgartner, Josef Simeoni, Roland Zelger, Harald Schennach, Cornelia Lass-Flörl, Renate Edelhofer, Kurt Pfister, Andrea Milhakov, Gernot Walder
Transfusion. 2014 Jul;54(7):1725-32. doi: 10.1111/trf.12606. Epub 2014 Mar 28.
Background: After malaria, babesiosis is the second most common transfusion-transmitted parasitic disease in the United States. In Europe, one reported transfusion case, concerning Babesia microti, occurred in Germany.
Study design and methods: Due to the fact that Babesia spp. are present in Tyrolean ticks, the aim of this study is to assess the occurrence of immunoglobulin (Ig)G antibodies against the Babesia divergens complex, including B. divergens and Babesia venatorum (EU1), as well as B. microti by screening a representative collective of 988 blood donors from North and East Tyrol (Austria) with indirect immunofluorescence antibody test. Additionally, we investigated 206 local ixodid ticks for the presence of babesial DNA by polymerase chain reaction.
Results: Seroprevalence data resulted in rates of 2.1% for IgG antibodies against the B. divergens complex and 0.6% against B. microti in Tyrolean blood donors. All sera could be confirmed by independent retesting. Our data indicate that cross-reactivity is high between B. divergens and B. venatorum and lower than 19.8% between B. divergens and B. microti.
Conclusions: This study shows that Babesia spp. are present in the Tyrols, which blood donors come into serologic contact with, and that we have to consider how to sustain blood product safety concerning this new challenge. Additionally, it is the first description of B. venatorum in the Tyrols, found in one Ixodes ricinus at the Italian border.
Links: PMID: 24673158; DOI: 10.1111/trf.12606